Vidarabine Other names: Arabinoside Adenine 9-β-D-arabinofuranosyladenine

Chemical formula: C₁₀H₁₃N₅O₄  Molecular mass: 267.241 g/mol  PubChem compound: 21704

Active ingredient description

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code Group title Classification
J05AB03 Vidarabine J Antiinfectives for systemic use → J05 Antivirals for systemic use → J05A Direct acting antivirals → J05AB Nucleosides and nucleotides excl. reverse transcriptase inhibitors
Discover more medicines within J05AB03
S01AD06 Vidarabine S Sensory organs → S01 Ophthalmologicals → S01A Antiinfectives → S01AD Antivirals
Discover more medicines within S01AD06

Structural formula

Graphic representation of the active ingredient's molecular structure

External identifiers

CAS Substance: 5536-17-4
DrugBank Drug: DB00194
KEGG Drug: D00406
PubChem Compound: 21704
RxNorm Ingredient: 11194
SNOMED-CT Concept: 373759007
Vidarabine (substance)
UNII Identifier: FA2DM6879K
VIDARABINE

Medicines

Vidarabine is an active ingredient of these brands:

Japan (JP)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.

 
Next: Usage >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈